Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

BioIVT expands blood product offerings
December 2018
SHARING OPTIONS:

WESTBURY, N.Y.—The fourth quarter of 2018 saw BioIVT share news of its acquisition of London-based Clinical Trials Laboratory Services (CTLS), which offers high-quality serum, plasma and blood collection services in addition to full-service processing capabilities. Financial details were not released, but BioIVT noted in a press release that all CTLS employees will be joining BioIVT, and the London headquarters of CTLS will function as the combined company's primary European site for donor collections.
 
“We are delighted that CTLS is now part of BioIVT,” said BioIVT CEO Jeff Gatz. “This is BioIVT’s first donor center in Europe, and we are excited to be able to address our clients’ needs by offering fresh blood and blood-derived products. CTLS expands our immune cell offering, which is one of the fastest growing segments of our company. This acquisition increases our capabilities and improves the efficiency with which we can deliver high-quality biospecimens to our clients in Europe.”

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.